Si-Yu Wu Selected Research

2,4-diaminohypoxanthine

1/2021

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Si-Yu Wu Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 01/2021
2	Adenoma (Adenomas) 01/2017 - 10/2013
2	Wounds and Injuries (Trauma) 08/2012 - 10/2011
1	Bites and Stings (Sting) 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Arthritis (Polyarthritis) 03/2013
1	Infections 11/2012
1	Gunshot Wounds (Gunshot Wound) 08/2012

Drug/Important Bio-Agent (IBA)

2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2019
2	theasinensin AIBA 01/2017 - 10/2013
2	Bromelains (Bromelain)IBA 08/2012 - 10/2011
1	5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAHP)IBA 01/2021
1	2,4-diaminohypoxanthineIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Decitabine FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Oxygen (Dioxygen)IBA 08/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2012
1	SolutionsIBA 10/2011

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2011
2	Neoadjuvant Therapy 01/2021 - 01/2019
2	Immunotherapy 01/2021 - 01/2021
2	Debridement 08/2012 - 10/2011
1	Segmental Mastectomy (Lumpectomy) 01/2020
1	Distraction Osteogenesis 03/2013